RenovaCare, Inc. (RCAR) Research

RenovaCare, Inc. is an emerging biotechnology and medical device enterprise primarily focused on pioneering and commercializing autologous cellular therapies. These innovative treatments are intended for both clinical and aesthetic applications. The company is actively developing two key technologies: the CellMist System, a specialized method for isolating cells to aid in the regeneration of human skin, and the SkinGun, a device designed to precisely deliver these cells to the targeted treatment area. RenovaCare also maintains a strategic partnership with StemCell Systems GmbH, collaborating on techniques for isolating and applying self-donated stem cells to stimulate tissue and organ regeneration. Formerly known as Janus Resources, Inc., the company officially adopted the name RenovaCare, Inc. in January 2014. Its operations are headquartered in Scottsdale, Arizona.

Market snapshot

Symbol
RCAR
Price
$0.00
Day change
0.00%
Market cap
$8.7K
P/E ratio
-0.00x
52-week range
0.0001-0.0002
Sector
Healthcare
Industry
Biotechnology

Peer companies

  • American Scientific Resources, Incorporated (ASFX)
  • Lowell Farms Inc. (LOWLF)
  • Medite Cancer Diagnostics, Inc. (MDIT)
  • Strategic Partners A/S (OZYMF)
  • Poniard Pharmaceuticals, Inc. (PARD)
  • Q BioMed Inc. (QBIO)
  • Regenicin, Inc. (RGIN)
  • Scopus BioPharma Inc. (SCPS)

Recent insider activity

  • Kirkland Kenneth — A-Award (50000 shares) on 2016-03-16
  • Bold Thomas — A-Award (60000 shares) on 2015-03-16
  • Rosen Rhonda Beth — A-Award (20000 shares) on 2016-03-16
  • SIERCHIO JOSEPH — A-Award (50000 shares) on 2016-03-16
  • RAYAT HARMEL S — P-Purchase (2173913 shares) on 2016-02-02

Open RenovaCare, Inc. (RCAR) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.